CION Investment Earnings Call Transcripts
Fiscal Year 2026
-
Net investment income and NAV declined quarter-over-quarter due to lower transaction fees, higher interest expense, and unrealized mark-to-market losses, but portfolio credit quality remained stable. Management remains optimistic, continues share repurchases, and targets lower leverage over the coming quarters.
Fiscal Year 2025
-
Core first lien portfolio remains healthy with increased interest coverage and low non-accruals. NAV declined 7.4% due to unrealized equity marks, but balance sheet flexibility improved with $307.5 million in new unsecured debt and continued share repurchases.
-
Q3 saw net investment income surge to $0.74 per share and NAV rise 2.5% to $14.86, driven by strong transaction activity and equity gains. Share repurchases and a shift to monthly distributions in 2026 were announced, with portfolio credit quality remaining robust.
-
Q2 net investment income was $0.32 per share, below the $0.36 dividend due to one-time impacts, but NAV rose 1.5% to $14.50. Share repurchases accelerated, and a $20 million buyback upsize was authorized. Management expects improved earnings and continued strong credit performance.
-
The meeting confirmed quorum, approved the election of three independent directors for three-year terms, and ratified RSM U.S. LLP as auditor for 2025. All proposals passed as presented.
-
Q1 2025 net investment income rose to $0.36 per share, covering the dividend, while NAV declined 7.5% to $14.28 due to mark-to-market losses in select investments. Portfolio credit quality remains strong, with low non-accruals and a defensive, first lien focus.
Fiscal Year 2024
-
Reported strong 2024 results with net investment income exceeding distributions and a robust, mostly first-lien portfolio. NAV declined due to equity marks and special dividends, but credit quality remains strong. Maintained a flexible balance sheet and active capital management.
-
Q3 net investment income of $0.40 per share exceeded the $0.36 dividend, but NAV declined to $15.73 due to equity portfolio marks. A major baby bond offering and debt refinancing enhanced balance sheet flexibility, while credit performance remained strong despite increased non-accruals.
-
The meeting confirmed a quorum, approved Proposal 2 to allow share sales below net asset value, and concluded without further business or shareholder questions. Proxy procedures and proper notice were affirmed.
-
Q2 saw strong net investment income, modest NAV growth, and continued defensive portfolio management amid a competitive lending environment. Share repurchases and a reduced cost of capital supported shareholder value, while non-accruals rose slightly but remained low.